Dossier assessment

Cenobamate (epilepsy) - Benefit assessment according to §35a Social Code Book

Status
Status: Commission completed
Project no.
A21-78
Last updated

Report documents

  1. Extract of dossier assessment

    Cenobamate (epilepsy) - Benefit assessment according to §35a Social Code Book

    published on
    Document type
    PDF document, 496 kB, EN, not accessible
  2. Dossier assessment

    Cenobamate (epilepsy) - Benefit assessment according to §35a Social Code Book

    published on
    Document type
    PDF document, 622 kB, DE, not accessible

Dossier assessment

Indication:

Adjunctive treatment of focal-onset seizures with or without secondary generalization in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products

Result of dossier assessment:

Added benefit not proven.

Additional information

Federal Joint Committee (G-BA)

19-11-2021 A G-BA decision was published.

G-BA documents on this decision

Project details

Project no.
A21-78
Commission
Commission awarded on 31.05.2021 by the Federal Joint Committee (GBA).
Report type
Dossier assessment
Status
Commission completed
Department/Division
Drug Assessment
Topic
Head and nerves
Note

After completion of the assessment by IQWiG the Federal Joint Committee (GBA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the GBA website.

Connected Projects

  1. Addendum

    Cenobamate (epilepsy) - Addendum to Commission A21-78

    Project no.
    G21-30
    Last updated

    Status: Commission completed

Contact

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form